Finally, the independent prognostic impact of CREBBP mutations was further evaluated by comparing the CREBBP group (n = 84) against all other patients in the pan-cancer cohort (WT CREBBP) (Figure 12B). The gene discussed is CREBBP; the disease is cancer.